Table 2. Rating Scales Used in Clinical Trials for Schizophrenia in 2004 (38 Studies).
| DOMAINS | SCALES | PERCENTAGE UTILIZED |
|---|---|---|
| Global evaluation | ANY scales | 50% |
| CGI | 50% | |
| Classical psychopathology | ANY scales | 95% |
| PANSS | 79% | |
| BPRS | 29% | |
| Affective/Anxiety symptoms | ANY scales | 32% |
| HRSD | 11% | |
| EPS | ANY scales | 50% |
| SAS | 29% | |
| AIMS | 29% | |
| BARS | 16% | |
| ESRS | 13% | |
| Non-motor A/Es | ANY scales | 13% |
| UKU | 13% | |
| Functioning | ANY scales | 13% |
| GAF/GAS | 11% | |
| Subjective perspectives | ANY scales | 24% |
| Cognition | ANY scales | 11% |
| Others | ANY scales | 21% |
Abbreviations (also see Table 1): ESRS extrapyramidal symptom rating scale; UKU Udvalg for Kliniske Undersogelser side effect rating scale.